Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

Rhenium-188 ((188)Re) is a high energy beta-emitting radioisotope with a short 16.9 h physical half-life, which has been shown to be a very attractive candidate for use in therapeutic nuclear medicine. The high beta emission has an average energy of 784 keV and a maximum energy of 2.12 MeV, sufficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepareur, Nicolas, Lacœuille, Franck, Bouvry, Christelle, Hindré, François, Garcion, Emmanuel, Chérel, Michel, Noiret, Nicolas, Garin, Etienne, Knapp, F. F. Russ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587137/
https://www.ncbi.nlm.nih.gov/pubmed/31259173
http://dx.doi.org/10.3389/fmed.2019.00132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587137/
https://www.ncbi.nlm.nih.gov/pubmed/31259173
http://dx.doi.org/10.3389/fmed.2019.00132

Ejemplares similares